Opportunistically Detecting Signs of Hypertension on a Consumer Smartwatch.
Smartwatches could routinely flag potential high blood pressure, though confirmed diagnosis with a cuff remains essential.
A prospective multicenter study validated a smartwatch photoplethysmography and accelerometry algorithm against 24-hour ambulatory blood-pressure monitoring in 196 adults. Its 65.8% sensitivity and 90.0% specificity suggest a scalable route to opportunistic hypertension screening, although confirmatory cuff-based diagnosis remains necessary.
What the study was
- Study design
- Prospective multicenter diagnostic validation study
- Population
- Adults without known cardiovascular disease or antihypertensive medication
- Sample size
- 196
- Category
- Diagnostics
- Maturity
- Validated
- Journal
- Nature
Why it surfaced
Prospective multicenter validation against a clinical reference standard gives this AI diagnostic study strong near-term population-health relevance.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.